JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 11 No. 7 459-466
© 1970 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Winchell, H. S.
Right arrow Articles by Edwards, C. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Winchell, H. S.
Right arrow Articles by Edwards, C. L.

Visualization of Tumors in Humans Using 67Ga-Citrate and the Anger Whole-Body Scanner, Scintillation Camera and Tomographic Scanner

H. S. Winchell, P. D. Sanchez, C. K. Watanabe, L. Hollander, H. O. Anger and J. McRae*

Donner Laboratory, University of California, Berkeley, California

R. L. Hayes and C. Lowell Edwards

Oak Ridge Associated Universities, Oak Ridge, Tennessee

Correspondence: For reprints contact: H. S. Winchell, Donner Laboratory and Donner Pavilion, University of California Berkeley, Berkeley, Calif. 94720.

ABSTRACT

The 67Ga-citrate was administered to 18 patients with a variety of malignant neoplasias. In 11 patients definite abnormal localization of the 67Ga in tumors occurred. Positive results were obtained in all five patients with lymphoma. The Anger whole-body counter, scintillation camera and tomographic scanner all generally showed good resolution of the tumor from surrounding tissue. However, the tomographic scanner had the advantage of also indicating the depth of tumor within the body. Generally when the 67Ga localized in tumors, not all of the tumor mass within the body of the patient showed such accumulation, suggesting that variations in metabolic activity or vascular perfusion of the tumor were responsible for the localization.

Gallium-67 administered as the citrate can localize in a variety of non-neoplastic soft tissues. In the present study 67Ga was noted in gynecomastia and variably in the pelvis of female patients. In several cases, the marked localization of the 67Ga within the body appeared to give information concerning the presence of a tumor which could not be obtained by use of other clinical detection methods. These results suggest that chelated carrier-free metals, such as 67Ga, will prove clinically useful in evaluating the presence and distribution of malignant neoplastic tissue in human subjects.

FOOTNOTES

* On sabbatical leave from University of Sydney, Sydney, Australia.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1970 by the Society of Nuclear Medicine.